Form 483

Merck Sharp & Dohme LLC Form 483, 2014-09-12

FDA issued a Form 483 to Merck Sharp & Dohme LLC on 2014-09-12 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Merck Sharp & Dohme LLC · West Point, United States · Issued September 12, 2014

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Sep 2014
21 CFR 211.160(b)(1)

Incoming lots - conformance to written specs-

Cited by Anita R Michael, Junho Pak

12 Sep 2014
21 CFR 211.160(b)(4)

Instruments, apparatus, et. al. not meeting specs

Cited by Anita R Michael, Junho Pak

12 Sep 2014
21 CFR 211.194(a)(2)

Suitability of testing methods verified

Cited by Anita R Michael, Junho Pak

Inspected site

MSMerck Sharp & Dohme LLCWest Point, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere